Jens‐Kerim Ergüden

530 total citations
8 papers, 423 citations indexed

About

Jens‐Kerim Ergüden is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Jens‐Kerim Ergüden has authored 8 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Jens‐Kerim Ergüden's work include Nitric Oxide and Endothelin Effects (2 papers), Organophosphorus compounds synthesis (2 papers) and Phosphorus compounds and reactions (1 paper). Jens‐Kerim Ergüden is often cited by papers focused on Nitric Oxide and Endothelin Effects (2 papers), Organophosphorus compounds synthesis (2 papers) and Phosphorus compounds and reactions (1 paper). Jens‐Kerim Ergüden collaborates with scholars based in Germany, United States and Japan. Jens‐Kerim Ergüden's co-authors include Harold W. Moore, Peter Kolkhof, Heike Heckroth, Alexander Kühl, Karl‐Heinz Schlemmer, Santiago Figueroa‐Pérez, Lars Bärfacker, Rolf Grosser, Heike Gielen‐Haertwig and Johannes Platzek and has published in prestigious journals such as British Journal of Pharmacology, Organic Letters and Synthesis.

In The Last Decade

Jens‐Kerim Ergüden

8 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens‐Kerim Ergüden Germany 6 170 147 107 73 65 8 423
Tadeu L. Montagnoli Brazil 12 56 0.3× 127 0.9× 71 0.7× 118 1.6× 110 1.7× 21 396
James S. Bean United States 11 111 0.7× 161 1.1× 58 0.5× 18 0.2× 94 1.4× 16 414
Peter B. Ehmer Germany 8 232 1.4× 176 1.2× 86 0.8× 99 1.4× 46 0.7× 12 584
N Hayakawa Japan 9 98 0.6× 127 0.9× 64 0.6× 81 1.1× 9 0.1× 37 390
Karen M. Zimmerman United States 8 104 0.6× 108 0.7× 97 0.9× 14 0.2× 109 1.7× 11 368
Christina M. Barrett United States 11 82 0.5× 160 1.1× 107 1.0× 81 1.1× 21 0.3× 16 445
Denise Blum‐Kaelin Switzerland 9 145 0.9× 173 1.2× 65 0.6× 13 0.2× 50 0.8× 11 445
Yuichi Koga Japan 12 223 1.3× 386 2.6× 259 2.4× 37 0.5× 28 0.4× 22 807
Andreas Böttcher Germany 10 58 0.3× 207 1.4× 80 0.7× 14 0.2× 54 0.8× 18 533
Dirk Trommeshauser Germany 14 156 0.9× 254 1.7× 24 0.2× 74 1.0× 17 0.3× 21 713

Countries citing papers authored by Jens‐Kerim Ergüden

Since Specialization
Citations

This map shows the geographic impact of Jens‐Kerim Ergüden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Kerim Ergüden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Kerim Ergüden more than expected).

Fields of papers citing papers by Jens‐Kerim Ergüden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens‐Kerim Ergüden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Kerim Ergüden. The network helps show where Jens‐Kerim Ergüden may publish in the future.

Co-authorship network of co-authors of Jens‐Kerim Ergüden

This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Kerim Ergüden. A scholar is included among the top collaborators of Jens‐Kerim Ergüden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Kerim Ergüden. Jens‐Kerim Ergüden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Beck, Hartmut, Friederike Stoll, Ingo Flamme, et al.. (2018). Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia. ChemMedChem. 13(10). 988–1003. 61 indexed citations
3.
Bärfacker, Lars, Alexander Kühl, Alexander Hillisch, et al.. (2012). Discovery of BAY 94‐8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases. ChemMedChem. 7(8). 1385–1403. 199 indexed citations
4.
Wunder, Frank, Hanna Tinel, R. Kast, et al.. (2010). Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor. British Journal of Pharmacology. 160(2). 399–409. 66 indexed citations
5.
Brands, Michael, Jens‐Kerim Ergüden, Kentaro Hashimoto, et al.. (2005). Novel, selective indole-based ECE inhibitors: Lead optimization via solid-phase and classical synthesis. Bioorganic & Medicinal Chemistry Letters. 15(19). 4201–4205. 15 indexed citations
6.
Brands, Michael, Jens‐Kerim Ergüden, Kentaro Hashimoto, et al.. (2005). Selective Indole‐Based ECE Inhibitors: Synthesis and Pharmacological Evaluation. ChemMedChem. 1(1). 96–105. 8 indexed citations
7.
Ergüden, Jens‐Kerim & Harold W. Moore. (1999). A New Tandem Route to Angular Tetraquinanes. Synthesis of the Waihoensene Ring System. Organic Letters. 1(3). 375–378. 69 indexed citations
8.
Ergüden, Jens‐Kerim & Ernst Schaumann. (1996). Phosphoryl Functionalized Bishomoallyl Alcohols by Ring Opening of Epoxides with Lithiated Allyldiphenylphosphane Oxide. Synthesis. 1996(6). 707–710. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026